NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
Crash Information
When hospital research staff were allowed to be in patient care areas, they were able to listen to EMS reports being provided to the treating staff and record details of the crash on the data collection cards. This information was supplemented by reviews of EMS run sheets and hospital records that contained details on the crash. The study also reviewed crash reports when available to verify crash details. When access to patient care areas was restricted during the public health emergency, the study relied more heavily on EMS run sheets, hospital records, and crash reports to gather crash details. No personal identifiers were ever entered into the study database.
Selected Drugs
NHTSA research traditionally focuses on testing for those drugs that are known, or suspected, to impair cognitive and motor skills important for driving safety. These include alcohol as well as OTC, prescription, and illegal drugs. The results of the prior NRSs, the Washington roadside survey, and Virginia Beach study formed the foundation for the drugs selected for analysis in the present study. Table 6 contains the list of the parent drugs and metabolites included in this study's toxicological testing.
Table 6. Selected Drugs and Metabolites for Toxicology Testing
| Class/Category | Parent Drug or Metabolite (Abbreviation) |
|---|---|
| Alcohol | ethyl alcohol |
| Cannabinoids | delta-9-tetrahydrocannabinol (<math>\Delta</math>-9-THC), 11-hydroxy-<math>\Delta</math>9-tetrahydrocannabinol (11-OH-THC), 11-nor-9-carboxy-<math>\Delta</math>9-tetrahydrocannabinol (11-COOH-THC)# |
| Stimulants | cocaine, benzoylecgonine (BZE)#, cocaethylene; amphetamine; methamphetamine; 3,4-methylenedioxy-methamphetamine (MDMA); 3,4-methylenedioxyamphetamine (MDA); ephedrine; pseudoephedrine; phenylpropanolamine; phentermine; methylphenidate |
| Sedatives Benzodiazepines Barbiturates Muscle Relaxers Sleep Aids |
diazepam; nordiazepam*; oxazepam*; temazepam*; clonazepam, 7-aminoclonazepam; alprazolam; lorazepam; chlordiazepoxide; midazolam; bromazepam; butalbital; secobarbital; phenobarbital; carisoprodol; meprobamate; cyclobenzaprine; zolpidem |
| Opioids | 6-monoacetylmorphine (6-AM)^; morphine*; codeine; hydrocodone; hydromorphone*; oxycodone; oxymorphone*; methadone, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP)#; buprenorphine norbuprenorphine; fentanyl, norfentanyl#; furanylfentanyl; acetylfentanyl; carfentanil; fluorofentanyl; tramadol |
| Antidepressants | sertraline; fluoxetine; amitriptyline; nortriptyline; imipramine; desipramine; citalopram; doxepin; venlafaxine; trazadone |
| Over the Counter | dextromethorphan; diphenhydramine; chlorpheniramine; doxylamine |
| Other | phencyclidine; ketamine; <math>\alpha</math>-pyrrolidinopentiophenone (alpha-PVP) |
Inactive metabolite.
*These compounds can be parent drugs or active metabolites of other drugs.
^Heroin can only be definitively detected by the presence of the 6-AM metabolite.
17
Keys: ← → or j k turn pages; / finds.